A new economic impact report details the financial contributions of the Cambridge Biomedical Campus (CBC), which celebrates its 60th anniversary this autumn. The independent report by the Centre for Economics and Business Research (Cebr) for the first time calculates the economic benefits of CBC also highlights the health and research benefits for the region.
Connect: Health Tech, the University of Cambridge Enterprise Zone, has today launched a roadmap, ‘Creating a University Enterprise Zone for Cambridge across the life and physical sciences’, that examines the challenges faced in futureproofing and sustaining the growth of the life sciences cluster to maintain Cambridge as a global centre of excellence for health tech.
Cambridge is to establish a University Enterprise Zone as part of a new government initiative announced today by Universities Minister Chris Skidmore.
A new research institute launching today is seeking to create a world-leading asset for the NHS by improving the science behind healthcare organisation and delivery.
A new collaboration between the University of Cambridge, Papworth Hospital NHS Foundation Trust and Sunway Medical Centre in Malaysia will see researchers and clinicians from the two countries working together across borders and disciplinary divides to tackle some of the world’s major health challenges.
With the official launch today of the next stage in the Government’s Life Sciences Industrial Strategy, Cambridge can have a key role to deliver jobs, growth and investment for the East of England.
When a drug fails late on in clinical trials it’s a major setback for launching new medicines. It can cost millions, even billions, of research and development funds. Now, an ‘adaptive’ approach to clinical trials and a genetic tool for predicting success are increasing the odds of picking a winner.
The Cambridge Animal Alphabet series celebrates Cambridge's connections with animals through literature, art, science and society. Here, F is for Fruit Fly and the myriad ways that they are helping with medical research.
One of the world’s leading childhood brain tumour experts, Professor Richard Gilbertson, has been appointed as Li Ka Shing Chair of Oncology in Cambridge and Director of the Cambridge Cancer Centre. He will take up his appointment in August.
Alzheimer’s Research UK, the world’s largest dedicated dementia research charity, has announced a £30 million Drug Discovery Alliance, launching three flagship Drug Discovery Institutes at the Universities of Cambridge, Oxford and UCL (University College London). The Drug Discovery Institutes will see 90 new research scientists employed in state-of-the-art facilities to fast-track the development of new treatments for Alzheimer’s disease and other dementias.
© 2025 University of Cambridge